Cantor Fitzgerald restated their overweight rating on shares of Vincerx Pharma (NASDAQ:VINC – Free Report) in a report released on Tuesday morning, Benzinga reports. Vincerx Pharma Price Performance VINC opened at $1.00 on Tuesday. Vincerx Pharma has a one year low of $0.61 and a one year high of $9.37. The company’s 50 day simple […]